International Journal of Drug Policy
Volume 21, Issue 5 , Pages 411-417, September 2010

Is UK drug policy evidence based?

University of Glamorgan, Centre for Criminology, Pontypridd, CF37 1DL, United Kingdom

Received 3 November 2009; received in revised form 20 January 2010; accepted 25 February 2010. published online 29 March 2010.

Abstract 

Background

All public services in the UK are expected to produce evidence-based policies. This principle was argued particularly strongly in relation to policies for tackling drug misuse. However, concerns have been expressed that commitment to this principle is not matched by the reality of policy making. In this paper, we examine the extent to which the UK drug strategy can be regarded as evidence-based.

Methods

Focusing on case studies of policies implemented as part of the four main strands of the strategy, evidence reported by the government as forming the basis of the policy is examined as are findings of the published sources of evidence cited.

Results

In most cases, the evidence was of a good quality in that it reflected the general standard of research in the area. The main problem lies in the interpretation and reporting of research results. Two of four case studies were reported as biased in terms of research study selection and in two there was some evidence that the reporting was not wholly representative of the conclusions drawn.

Conclusion

There are many factors that influence the generation of policy and it is unrealistic, and perhaps disingenuous, to suggest in relation to drugs policy, that evidence is its primary focus.

Keywords: Evidence-based, Evidence informed, Policy, Drug strategy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0955-3959(10)00046-0

doi:10.1016/j.drugpo.2010.02.004

International Journal of Drug Policy
Volume 21, Issue 5 , Pages 411-417, September 2010